focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK fraud head expects corporate plea deals, considers Libor charges

Tue, 25th Oct 2016 14:53

* SFO head David Green gives evidence to UK lawmakers

* Green says "significant" new DPAs on horizon

* Green says Serco probe looking at "different conduct"

By Kirstin Ridley

LONDON, Oct 25 (Reuters) - The UK Serious Fraud Office (SFO)expects to agree some "significant" corporate plea deals overthe coming months and is also considering filing more charges inthe Libor benchmark rate rigging investigation, its head said onTuesday.

The SFO's probe into alleged manipulation of benchmark ratessuch as Libor (London interbank offered rate), which began in2012, has so far resulted in five convictions and six acquittalsof individuals. Eight others face trial next year.

SFO director David Green told a parliamentary committee oflawmakers that there were also "some others" who it had todecide whether to charge.

Lawmakers asked whether the SFO had the resources to providea credible threat of prosecution if companies failed to reportthemselves to the authorities when they discover wrongdoing.

Green said he had spent four years speaking at leastfortnightly with businesses and lawyers explaining theincentives behind self-reporting, while building up the agency'sintelligence division.

"You will see over the coming months some significantdeferred prosecution agreements (DPAs)," he said.

DPAs, effective plea deals introduced in Britain in 2014,were a useful tool to encourage good corporate conduct, Greensaid, and were available to those who report wrongdoingpromptly, cooperate, grant authorities access to factualdocuments and assist in prosecuting individuals.

A judge approved Britain's first DPA in November in a casecentred on $6 million in bribes paid to Tanzanian officials bythe Tanzanian unit of South Africa's Standard Bank.

Tesco is among companies cooperating with acriminal inquiry into accounting practices, launched after thesupermarket chain said it overstated half year profits in August2014 by about 260 million pounds ($320 million).

Green also said a new line of inquiry had also been openedin a three-year inquiry into global outsourcing group Serco, launched after an audit alleged the government had beencharged for tagging criminals who were either dead or in prison.

The SFO head gave no further details on the Libor inquiry, aglobal investigation in which it has charged around 20.

Barclays, which has seen 10 former traders chargedfor alleged benchmark rigging and admitted in 2012 tolow-balling, or artificially lowering, rates during the creditcrisis, reiterated in its 2015 annual report that it continuedto respond to information requests as part of an SFO inquiry. (Editing by Alexander Smith)

More News
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.